{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:09:20Z","timestamp":1789135760793,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jnma.2026.06.019","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:10:18Z","timestamp":1783437018000},"page":"934-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fulminant heart failure in a patient with MYPN-associated cardiomyopathy: A case report"],"prefix":"10.1016","volume":"118","author":[{"given":"Manroop","family":"Minhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2313-3947","authenticated-orcid":false,"given":"Abdullah","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4921-8962","authenticated-orcid":false,"given":"Fuad","family":"Hassuneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-9440","authenticated-orcid":false,"given":"Shawn","family":"Meepagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-013X","authenticated-orcid":false,"given":"Elizabeth","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3936-3070","authenticated-orcid":false,"given":"Syed Fahad","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jnma.2026.06.019_bib0001","first-page":"735","article-title":"Role of Z-disc proteins in cardiac structure, signaling, and disease","volume":"50","author":"Frank","year":"2011","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.jnma.2026.06.019_bib0002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.153.2.413","article-title":"Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies","volume":"153","author":"Bang","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jnma.2026.06.019_bib0003","article-title":"Myopalladin is essential for maintaining cytoskeletal architecture and enabling mechanotransduction in cardiomyocytes","volume":"9","author":"Hu","year":"2020","journal-title":"eLife"},{"issue":"9","key":"10.1016\/j.jnma.2026.06.019_bib0004","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/dds022","article-title":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations","volume":"21","author":"Purevjav","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.jnma.2026.06.019_bib0005","first-page":"1002","article-title":"Mutations in MYPN, encoding myopalladin, are responsible for restrictive cardiomyopathy","volume":"40","author":"Duboscq-Bidot","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jnma.2026.06.019_bib0006","article-title":"Genotypic and phenotypic analysis of 24 patients presenting MYPN variants","volume":"36","author":"Sevdali","year":"2023","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"10.1016\/j.jnma.2026.06.019_bib0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.14740\/cr1552","article-title":"Associations of MYPN, TTN, SCN5A, MYO6 and ELN mutations with arrhythmias and sudden cardiac death","volume":"14","author":"Paz-Cruz","year":"2023","journal-title":"Cardiol Res"},{"issue":"13","key":"10.1016\/j.jnma.2026.06.019_bib0008","article-title":"Dilated cardiomyopathy and later onset limb-girdle muscular dystrophy associated with Fukutin and Lamin A\/C mutations","volume":"31","author":"Cardona Perez","year":"2026","journal-title":"JACC Case Rep"},{"issue":"6","key":"10.1016\/j.jnma.2026.06.019_bib0009","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCRESAHA.113.300282","article-title":"Genetic evaluation of cardiomyopathy: a Heart Failure Society of America practice guideline","volume":"113","author":"Hershberger","year":"2013","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jnma.2026.06.019_bib0010","first-page":"241","article-title":"Genetic evaluation of cardiomyopathy: a Heart Failure Society of America perspective","volume":"3","author":"Hershberger","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"10.1016\/j.jnma.2026.06.019_bib0011","first-page":"887","article-title":"Role of genetic evaluation and screening in cardiomyopathies","volume":"24","year":"2022","journal-title":"J Mol Diagn"},{"issue":"8","key":"10.1016\/j.jnma.2026.06.019_bib0012","first-page":"1643","article-title":"Risk assessment and personalized treatment options in inherited cardiomyopathy","volume":"22","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jnma.2026.06.019_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jcsm.12486","article-title":"Myopalladin promotes muscle growth through modulation of the serum response factor pathway","volume":"11","author":"Filomena","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:32:21Z","timestamp":1789133541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968426001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0027968426001057"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2026.06.019","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fulminant heart failure in a patient with MYPN-associated cardiomyopathy: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2026.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Medical Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}